Calprotectin in inflammatory bowel disease

2020/08/17 by Fatemeh Khaki‐Khatibi, Fatemeh Khaki-Khatibi, Durdi Qujeq +5 · 27 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Immunology and Microbiology · #Inflammatory Bowel Disease #Microscopic Colitis #IL-33, ST2, and ILC Pathways

paper · doi:10.1016/j.cca.2020.08.025

Cited by

• Metagenome-informed metaproteomics of the human gut microbiome, host, and dietary exposome uncovers signatures of health and inflammatory bowel disease
• Palliative potential of genistein to counteract endosulfan instigated colon toxicity via regulating TLR4/MyD88, JAK1/STAT3 and NF-κB pathway: A biochemical and histological approach
• Fecal calprotectin in healthy children aged 4-16 years. [europepmc]
• Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy. [europepmc]
• Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis. [europepmc]
• Bioinformatis analysis reveals possible molecular mechanism of PXR on regulating ulcerative colitis. [europepmc]
• Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson's Disease. [europepmc]
• Can fecal calprotectin levels be used to monitor infant milk protein allergies? [europepmc]
• The Activity of Antimicrobial Peptides in Pediatric Celiac Disease. [europepmc]
• Elucidating the Role of Innate and Adaptive Immune Responses in the Pathogenesis of Canine Chronic Inflammatory Enteropathy-A Search for Potential Biomarkers. [europepmc]
• The value of fecal calprotectin in Clostridioides difficile infection: A systematic review. [europepmc]
• From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis. [europepmc]
• The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis. [europepmc]
• Development of a 32-gene signature using machine learning for accurate prediction of inflammatory bowel disease. [europepmc]
• Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis. [europepmc]
• Effects of a Low-FODMAP Diet on Irritable Bowel Syndrome in Both Children and Adults-A Narrative Review. [europepmc]
• Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis. [europepmc]
• Vitamin D Attenuates Ulcerative Colitis by Inhibiting ACSL4-Mediated Ferroptosis. [europepmc]
• A bibliometric and visual analysis of the use of ustekinumab in Crohn's disease using CiteSpace. [europepmc]
• Inflammation, the kynurenines, and mucosal injury during human experimental enterotoxigenic Escherichia coli infection. [europepmc]
• Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations. [europepmc]
• Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains. [europepmc]
• Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options. [europepmc]
• Effects of Heat-Treated Bifidobacterium longum CECT-7347 Combined with Fibersol-2 on the Intestinal Health of Cats Submitted to an Abrupt Dietary Change: A Randomized Controlled Study. [europepmc]
• Raising the bar in ulcerative colitis management. [europepmc]
• The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease. [europepmc]
• Neutrophil Elastase and Elafin in Inflammatory Bowel Diseases: Urinary Biomarkers Reflecting Intestinal Barrier Dysfunction and Proteolytic Activity. [europepmc]